News & Analysis
- Data & Tools
- Login | Register
Andrew Wasson is a partner in the New York office of Haug Partners. He has a broad range of experience in both the brand and generic sides of pharmaceuticals, especially regarding IP and regulatory law issues. Having grown up with a patent lawyer father, he has been involved in patents in one way or another for the better part of his life and has the advantage of being able to deal with complex patent law concepts in a very natural way. He is registered to practise before the US Patent and Trademark Office and has published extensively in both scientific and legal literature. He also serves on the editorial advisory board for the Food and Drug Law Institute’s Update magazine.
Unlock unlimited access to all IAM content